Neoplasia Clinical Trial
Official title:
The Suitability of Sniff Dog as a Tool in Screening Tumors-- a Prospective Observational Study
NCT number | NCT02049645 |
Other study ID # | Xiang-Ya 0001 |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | January 2014 |
Est. completion date | March 2026 |
Previous studies have demonstrated that sniff dogs can identify cancer patients from healthy subjects through sniffing exhaled breath air or blood or serum or urine or feces. It is hypothesized that sniff dogs may be used as a tool in screening cancer patients in health examination. Trained dogs will sniff serum from participants who are attending the annual health examination to identify potential or high risk subjects, and the results will be compared with the outcome of the traditional health examination, and the high risk subjects will be followed periodically for at least five years.
Status | Recruiting |
Enrollment | 4000 |
Est. completion date | March 2026 |
Est. primary completion date | December 31, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years and older |
Eligibility | Inclusion Criteria: - old than 20 years - currently without cancer diagnosed with pathological examination - allow the study team to examine his/her case history and incoming record Exclusion Criteria: - cancer patients with pathological diagnosis - who does not allow the study team to examine his/her case history and incoming record |
Country | Name | City | State |
---|---|---|---|
China | The Third Xiang-Ya Hospital | Changsha | Hunan |
Lead Sponsor | Collaborator |
---|---|
Chang-Qing Gao |
China,
Church J, Williams H. Another sniffer dog for the clinic? Lancet. 2001 Sep 15;358(9285):930. doi: 10.1016/S0140-6736(01)06065-2. No abstract available. — View Citation
Ehmann R, Boedeker E, Friedrich U, Sagert J, Dippon J, Friedel G, Walles T. Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J. 2012 Mar;39(3):669-76. doi: 10.1183/09031936.00051711. Epub 2011 Aug 18. — View Citation
Horvath G, Jarverud GA, Jarverud S, Horvath I. Human ovarian carcinomas detected by specific odor. Integr Cancer Ther. 2008 Jun;7(2):76-80. doi: 10.1177/1534735408319058. Epub 2008 May 27. — View Citation
McCulloch M, Jezierski T, Broffman M, Hubbard A, Turner K, Janecki T. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther. 2006 Mar;5(1):30-9. doi: 10.1177/1534735405285096. — View Citation
Willis CM, Church SM, Guest CM, Cook WA, McCarthy N, Bransbury AJ, Church MR, Church JC. Olfactory detection of human bladder cancer by dogs: proof of principle study. BMJ. 2004 Sep 25;329(7468):712. doi: 10.1136/bmj.329.7468.712. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | The substances used by the sniff dogs to identifying tumors | GCMS etc will be used to compare the volatile compounds between the sera from cancers patients and the from normal subjects, the suspected VOCs will be tested by the dog for conformation. | up to 5 years | |
Primary | Sensitivity and specificity in screening cancer patients | The results that obtained from the dogs will be compared with these of the pathological examinations. Sensitivity = the No. of patients identified by the dogs as cancers / the No. of patients suffering from cancer confirmed by pathological examination. Specificity = No. of subjects signaled by the dog as non-cancers / No. of subjects confirmed by pathological examination or the currently used methods as non-cancer subjects or at the end of the study, 5 years later still without cancer. | up to 5 years | |
Secondary | Behavior patterns of sniff dogs to different diseases | The behavior (lying before the tank for positive, neglecting the tanks) of the dog will be recorded and compared with the results of the pathological examination. | up to 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00339989 -
Cervical Cancer Early Endpoints and Determinants
|
||
Completed |
NCT01954836 -
Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial
|
N/A | |
Not yet recruiting |
NCT03979014 -
Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial
|
Phase 3 | |
Completed |
NCT02065297 -
Quantitative and Functional Study of TH17 Lymphocytes in Horton's Disease (HD)
|
||
Recruiting |
NCT02049658 -
The Sensitivity and Specificity of Sniff Dog as a Tool in Diagnosing the Suspected Tumor Patients
|
||
Completed |
NCT01523912 -
Radiofrequency Ablation for the Treatment of Gastric Dysplasia
|
Phase 4 | |
Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
Enrolling by invitation |
NCT00792649 -
Comparison Between HD+ Endoscopy and Standard Videoendoscopy in Screening Colonoscopy
|
N/A | |
Recruiting |
NCT05158712 -
Genetic Factors and Pheochromocytomas in Neoplasia Type 2
|
||
Completed |
NCT01962103 -
Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT01456143 -
Optical Imaging of Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04341181 -
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic Profiling
|
Phase 2 | |
Recruiting |
NCT02925234 -
The Drug Rediscovery Protocol (DRUP Trial)
|
Phase 2 |